CASC15 and neuroblastoma: Cancer susceptibility candidate 15, termed CASC15, located on chromosome 6p22, was reported to suppress the aggressive tumour progress; and the overexpression of its short isoform (CASC15-S) was found to inhibit neuroblastoma progression and increase patient survival [28].